Saturday, November 26, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma Class Action

PHILADELPHIA - Abbot, Teva, Barr and Duramed conspired to keep generic Niaspan off the market, an antitrust class action claims in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.